Antibiotic resistance of subgingival species in chronic periodontitis patients

Journal of Periodontal Research

Volumn 45, Issue 4, 2010, Pages 557-563

  Ardila, Carlos M ^a   Granada, M I ^a   Guzman I C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Antibiotic resistance; Antimicrobial(s); Microbiology; Periodontitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CLINDAMYCIN; HETEROCYCLIC COMPOUND; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVATIVE;

ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ARTICLE; CHRONIC PERIODONTITIS; CLASSIFICATION; COLOMBIA; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FUSOBACTERIUM NUCLEATUM; GINGIVA BLEEDING; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; PREVOTELLA; TOOTH PLAQUE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AGED; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN RESISTANCE; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAM RESISTANCE; CHRONIC PERIODONTITIS; CLINDAMYCIN; COLOMBIA; DENTAL PLAQUE; DRUG RESISTANCE, BACTERIAL; FEMALE; FUSOBACTERIUM NUCLEATUM; GINGIVAL HEMORRHAGE; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; PREVOTELLA; QUINOLINES;

EID: 77954852286     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2010.01274.x     Document Type: Article

References (52)

1. Genco RJ, Kornman KS, William R. Consensus report periodontal diseases: pathogenesis and microbiological factors. Ann Periodontol 1996, 1:926-932.
2. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003, 74:111-118.
3. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999, 20:136-167.
4. Rudney JD, Chen R, Sedgewick GJ. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001, 69:2700-2707.
5. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog 1995, 78:19-34.
6. Sanz M, Teughels W. Innovations in non-surgical periodontal therapy: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008, 35:3-7.
7. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008, 35(Suppl 8):45-66.
8. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. J Clin Periodontol 2007, 34:243-253.
9. Haffajee AD, Patel M, Socransky SS. Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol 2008, 23:48-57.
10. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol 2006, 33:254-264.
11. Ribeiro Edel P, Bittencourt S, Zanin IC. Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis. J Periodontol 2009, 80:1254-1264.
12. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol 2002, 73:1188-1196.
13. Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J Periodontol 2001, 72:1241-1245.
14. Guentsch A, Jentsch H, Pfister W, Hoffmann T, Eick S. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. J Periodontol 2008, 79:1894-1903.
15. Albandar JM. Periodontal diseases in North America. Periodontol 2000 2002, 29:31-69.
16. Sheiham A, Netuveli GS. Periodontal diseases in Europe. Periodontol 2000 2002, 29:104-121.
17. Mosca A, Miragliotta L, Iodice MA, Abbinante A, Miragliotta G. Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. Int J Antimicrob Agents 2007, 30:521-524.
18. Herrera D, van Winkelhoff AJ, Dellemijn-Kippuw N, Winkel EG, Sanz M. Beta-lactamase producing bacteria in the subgingival microflora of adult patients with periodontitis. A comparison between Spain and The Netherlands. J Clin Periodontol 2000, 27:520-525.
19. Gjermo P, Rosing CK, Susin C, Oppermann R. Periodontal diseases in Central and South America. Periodontol 2000 2002, 29:70-78.
20. Valenzuela MT, de Quadros C. Antibiotic resistance in Latin America: a cause for alarm. Vaccine 2009, 27(suppl 3):C25-C28.
21. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999, 4:1-6.
22. Möller AJ. Microbiological examination of root canals and periapical tissues of human teeth. Methodological studies. Odontol Tidskr 1966, 74(suppl):1-380.
23. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol 1986, 1:48-57.
24. Slots J, Reynolds HS. Long-wave UV light fluorescence for identification of black-pigmented Bacteroides spp. J Clin Microbiol 1982, 16:1148-1151.
25. Ambler J, Rennie R, Poupard J. Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines. Diagn Microbiol Infect Dis 2008, 61:49-57.
26. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007, 57:7-13.
27. van Winkelhoff AJ, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999, 20:122-135.
28. Herrera D, Contreras A, Gamonal J. Subgingival microbial profiles in chronic periodontitis patients from Chile, Colombia and Spain. J Clin Periodontol 2008, 35:106-113.
29. Kulik EM, Lenkeit K, Chenaux S, Meyer J. Antimicrobial susceptibility of periodontopathogenic bacteria. J Antimicrob Chemother 2008, 61:1087-1091.
30. Kuriyama T, Williams DW, Yanagisawa M. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral Microbiol Immunol 2007, 22:285-288.
31. Eick S, Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. J Periodontol 2004, 75:1327-1334.
32. Eick S, Schmitt A, Sachse S, Schmidt KH, Pfister W. In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. J Antimicrob Chemother 2004, 54:553-556.
33. Milazzo I, Blandino G, Musumeci R, Nicoletti G, Lo Bue AM, Speciale A. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents 2002, 20:451-456.
34. van Winkelhoff AJ, Herrera D, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol 2000, 27:79-86.
35. Jaramillo A, Arce RM, Herrera D, Betancourth M, Botero JE, Contreras A. Clinical and microbiological characterization of periodontal abscesses. J Clin Periodontol 2005, 32:1213-1218.
36. Tribble GD, Lamont GJ, Progulske-Fox A, Lamont RJ. Conjugal transfer of chromosomal DNA contributes to genetic variation in the oral pathogen Porphyromonas gingivalis. J Bacteriol 2007, 189:6382-6388.
37. Lakhssassi N, Elhajoui N, Lodter JP, Pineill JL, Sixou M. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study. Oral Microbiol Immunol 2005, 20:244-252.
38. Johnson CC. Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States. Clin Infect Dis 1993, 16:S371-S376.
39. King A, Downes J, Nord CE, Phillips I. Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe. Clin Microbiol Infect 1999, 5:404-416.
40. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 2005, 32:893-898.
41. Sobottka I, Cachovan G, Sturenburg EM. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 2002, 46:4019-4021.
42. Luong N, Tsai J, Chen C. Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline. Antimicrob Agents Chemother 2001, 45:3253-3255.
43. Handal T, Olsen I, Walker CB, Caugant DA. Detection and characterization of b-lactamase genes in subgingival bacteria from patients with refractory periodontitis. FEMS Microbiol Lett 2005, 242:319-324.
44. Müller HP, Holderrieth S, Burkhardt U, Höffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol 2002, 29:736-742.
45. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001, 357:1851-1853.
46. Pavicic MJ, van Winkelhoff AJ, De Graaff J. In vitro susceptibility of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992, 36:2634-2638.
47. Winkel EG, Van der Weijden GA, Van Winkelhoff AJ, Timmerman MF, Van der Velden U. Metronidazole plus amoxicillin in the treatment of adult periodontitis patients. A double-blind placebo controlled study. J Clin Periodontol 2001, 28:296-305.
48. Filippini M, Masiero G, Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 2006, 22:77-92.
49. Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 2003, 20:246-252.
50. Sedlacek MC, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol 2007, 22:333-339.
51. Martone WJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001, 33:S67-S68.
52. Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S. The antimicrobial resistance containment and surveillance approach--a public health tool. Bull World Health Organ 2004, 82:928-934.